0001725160-24-000113.txt : 20240509 0001725160-24-000113.hdr.sgml : 20240509 20240509194738 ACCESSION NUMBER: 0001725160-24-000113 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240509 DATE AS OF CHANGE: 20240509 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Zentalis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001725160 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 823607803 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-39263 FILM NUMBER: 24932517 BUSINESS ADDRESS: STREET 1: 1359 BROADWAY, SUITE 801 CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: (212) 433-3791 MAIL ADDRESS: STREET 1: 1359 BROADWAY, SUITE 801 CITY: NEW YORK STATE: NY ZIP: 10018 FORMER COMPANY: FORMER CONFORMED NAME: Zentalis Pharmaceuticals, LLC DATE OF NAME CHANGE: 20200107 FORMER COMPANY: FORMER CONFORMED NAME: Zeno Pharma, LLC DATE OF NAME CHANGE: 20171212 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: HAUSMAN DIANA CENTRAL INDEX KEY: 0001563992 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O ONCOTHYREON INC. STREET 2: 2601 FOURTH AVE, SUITE 500 CITY: SEATTLE STATE: WA ZIP: 98121 FORMER COMPANY: FORMER CONFORMED NAME: HAUSMAN DIANE DATE OF NAME CHANGE: 20121207 144 1 primary_doc.xml 144 0001563992 XXXXXXXX LIVE 0001725160 Zentalis Pharmaceuticals, Inc. 001-39263 1359 BROADWAY Suite 801 New York NY 10018 212-433-3791 Diana Hausman Chief Medical Officer Common Morgan Stanley Smith Barney LLC

1 New York Plaza, 38th Floor New York NY 10004

3356 42356.41 71026477 05/09/2024 NASDAQ Common 05/09/2024 Restricted Stock Unit Release Issuer N 3356 05/09/2024 NA Y The sale reported in this Form 144 was to satisfy withholding tax obligations upon the vesting of restricted stock units. 05/09/2024 /s/ Andrea Paul, attorney-in-fact for Diana Hausman